At a glance

IRRAS AB is a global commercial stage medical device company focused on bringing needed innovation to neurocritical care. Patients suffering from traumatic brain injury and intracranial bleeding are critically ill, often with life-threatening conditions but are generally treated with technologies that were introduced more than 30 years ago. IRRAS´ products have been designed to address complications associated with these traditional treatment methods, thereby improving patient outcomes, reducing treatment time, and decreasing the overall cost of care. IRRAS AB (publ) is listed on Nasdaq Stockholm (ticker: IRRAS).

OUR PRODUCTS

IRRAflow® is the company´s FDA-cleared and CE-marked medical device system that enables both intelligent intracranial fluid management and accurate real-time monitoring of intracranial pressure (ICP). The Hummingbird® product line includes several FDA-cleared products that help physicians diagnose and manage ICP.

IRRAS is well positioned to establish a leadership position in the medical device market with this unique and comprehensive product portfolio that is protected by multiple patents and patent applications.  IRRAS maintains its headquarters in Stockholm, Sweden, with corporate offices in Munich, Germany, and San Diego, California, USA